Post entry

Artimplant B nästa kursraket!!!

Please note: Community posts are written by its members and not by Redeye’s research department. As a reader you’re always encouraged to critically analyze the content.

Stort fokus i USA på SBI igår. Fick hög betyg av WSJ:

Small Bone Innovations, Inc. Ranked #24 in VentureSource Survey to Identify Top 50 US Based Venture Capital-Backed Companies

Press Release Source: Small Bone Innovations, Inc. On Wednesday April 14, 2010, 10:22 am EDT

NEW YORK--(BUSINESS WIRE)--Small Bone Innovations, Inc. (SBi), a leading privately-held orthopedic company focused exclusively on technologies and treatments for the small bones & joints, ranked #24 on a survey conducted by Dow Jones VentureSource and published in The Wall Street Journal (both owned by News Corporation) to identify the Top 50 venture capital-backed U.S. companies. Additionally, SBi was one of the seven (7) Healthcare companies and the only Orthopedic company to be ranked in the Top 50.

Almost 5,200 VC-backed firms were analyzed by VentureSource by assessing the track record of a company’s founders, management and investors, the amount of capital raised in the past three years and the percentage change in the company’s valuation in the 12 months ending November 30, 2009. The survey was published by The Wall Street Journal on March 9, 2010.

Anthony G. Viscogliosi, SBi Chairman & CEO, noted: “This ranking rewards the efforts of our employees and stakeholders for producing innovative products and underlines the value of our strategy to identify and leverage surgeon and patient demand for better small bone and joint treatments, especially total ankle arthroplasty.”



Frost & Sullivan selected SBi as the recipient of its 2007 Frost & Sullivan Award for Entrepreneurial Company of the Year.

SBi was named as one of the Red Herring Global 100 – a group of the most promisingtechnology companies in the world - selected from a list of 1800 entrants.


SBi was named in the Red Herring North America 100, recognizing SBi as one of the nation’s leading technology companies and the only orthopedic device company selected.

SBi’s Artelon® CMC-I Spacer, developed for patients with osteoarthritis at the base of the thumb, was named by Medical Design Technology magazine in its 2006 “Year of Innovation” review as one of the most fascinating technologies in the medical device industry.

Medical Device & Diagnostic Industry magazine named SBi to its list of “50 Companies to Watch” in 2006, noting, “Small Bone Innovations is going against the grain in its determination to become a market leader in the small bone & joint device sector.”

About Small Bone Innovations, Inc.

Small Bone Innovations, Inc. (SBi) was founded in 2004 by Viscogliosi Brothers, LLC, (VB), a New York-based merchant banking firm that specializes in the musculoskeletal/orthopedics sector. VB created SBi as the first company to focus purely on small bones & joints. By integrating established companies and professionals in the field, SBi offers a broad, clinically proven portfolio of products and technologies to treat trauma and diseases in small bones & joints. Today, SBi has facilities in New York, NY, Morrisville, PA, Bourg-en-Bresse, France, Donaueschingen, Germany, and Kuala Lumpur, Malaysia.

For more information on SBi, please visit:

Forward-looking statements

This news release contains forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of risks and uncertainties impacting SBi’s business including increased competition; the ability of SBi to expand its operations and to attract and retain qualified professionals; technological obsolescence; general economic conditions; and other risks.


You need to to read and post comments.

Does this article violate Redeye’s Rules & Guidelines?